Immuno Oncology Assay Market to Reach USD 21.49 Billion by 2036 Driven by Precision Cancer Diagnostics, Biomarker Testing, and Personalized Immunotherapy Advancements
According to the latest market analysis by Future Market Insights (FMI), the immuno oncology assay market is entering a rapid expansion phase as healthcare systems increasingly prioritize precision oncology, biomarker-driven treatment strategies, and advanced clinical diagnostics supporting personalized cancer care and immunotherapy development. The market, valued at USD 7.04 billion in 2026, is projected to reach USD 21.49 billion by 2036,...
Read more









